Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil

International Journal of Impotence Research volume 13, pages 291–293 (2001)Cite this article

Abstract

The pathogenesis of Peyronie's disease still remains an enigma and few epidemiological studies are available. The purpose of this study was to determine the prevalence of Peyronie's disease in males older than 50 y. From 26 to 30 July 1998, 1071 men attended the ‘Prostate Cancer Awareness Week of Santa Casa Hospital, Porto Alegre, Brazil’. In the prostate exam they also consented to be screened for Peyronie's disease. They underwent the 5-item International Index of Erectile Function (IIEF-5) questionnaire for evaluation of the erectile condition. The presence of a well-defined plaque in the penis was the diagnostic criterion for Peyronie's disease. The men were examined by five senior residents, under supervision by the staff Urologist. Men younger than 50 y as well as patients under intracavernous injection therapy for erectile dysfunction were excluded from the study. χ2 test was used for statistical analysis. Nine hundred and fifty-four (89.1%) out of the 1071 men with a mean age of 62 y (ranging from 52 to 77) were included in the study. Peyronie's disease plaques were found in 35 men (3.67%). Eight hundred and forty-five (88.6%) were Caucasians. There was no significant statistical difference regarding age (P>0.05). The presence of erectile dysfunction in the men with Peyronie's disease and without this condition, was 68.6% and 53.5%, respectively (P>0.05). From this data we can conclude that the prevalence of Peyronie's disease is higher than in formerly reported studies. Further observations should be carried out in different communities and in other groups of patients in order to confirm our results.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Lowe FC, Brendler CB . Evaluation of the urologic patient. History physical examination, and urinalysis. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds). Campbell's Urology 6th Edition. WB Saunder Company: Philadelphia, PA 1992 chapter 8, 307–342

    Google Scholar 

  2. Rehman J, Benet A, Melman A . Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. Urology 1998 51, 620–626

    Article  CAS  Google Scholar 

  3. Schiavino D et al.. Imunologic findings in Peyronie's disease: a controlled study. Urology 1997 50, 766–768

    Article  Google Scholar 

  4. Leffel MS . Is there an immunogenetic basis for Peyronie's disease? J Urol 1997 157, 295–297

    Article  Google Scholar 

  5. El-Sakka AI et al.. Peyronie's disease is associated with an increase in transforming growth factor-B protein expression. J Urol 1997 158, 1391–1394

    Article  CAS  Google Scholar 

  6. Chilton CP, Castle WM, Westwood CA, Pryor JP . Factors associated in the aetiology of Peyronie's disease. Br J Urol 1982 54, 748–750

    Article  CAS  Google Scholar 

  7. Ralph DJ, Brooks MD, Bottazzo GF, Pryor JP . The treatment of Peyronie's disease with tamoxifen. Br J Urol 1992 70, 648–651

    Article  CAS  Google Scholar 

  8. Rhoden EL et al.. Is there any association between Peyronie's disease and serum collagen markers? Int J Impot Res 2000 12, 302–304

    Article  CAS  Google Scholar 

  9. Jordan GH, Schlossberg SM, Devine CJ . Surgery of the penis and urethra. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds). Campbell's Urology, 7th edition. WB Sauders Company: Philadelphia, PA 1998 3, Chap 107, 3316–3394

    Google Scholar 

  10. Schwarzer U et al.. Prevalence of Peyronie's disease—results of an 8,000 men survey. AUA 2000 Annual Meeting.

  11. Rosen RC, Cappelleri JC, Lipsky J, Peña BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999 11, 319–326

    Article  CAS  Google Scholar 

  12. Rosen RC et al.. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997 49, 822–830

    Article  CAS  Google Scholar 

  13. Iacono F et al.. Microstructural disorders of the tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction. J Urol 1993 150, 1806–1809

    Article  CAS  Google Scholar 

  14. Dunsmuir WD . Francois de LaPeyronie (1678–1747): the man and the disease he described. Br J Urol 1996 78, 613–622

    Article  CAS  Google Scholar 

  15. Telöken C et al.. Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol 1999 162, 2003–2005

    Article  Google Scholar 

  16. Devine CJ, Jordan GH, Shlossberg SM . Surgery of the penis and urethra. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds). Campbell's Urology, 6th edition. WB Saunder Company: Philadelphia, PA 1992 Chapter 83, 2957–3032

    Google Scholar 

  17. Altaffer LF, Jordan GH . Sonographic demonstration of Peyronie's disease. Urology 1981 27, 292–295

    Article  Google Scholar 

  18. Smith BH . Subclinical Peyronie's disease. Am J Path 1969 52, 385–390

    CAS  Google Scholar 

  19. Lindsay MB et al.. The incidence of Peyronie's disease in Rochester, Minnesota 1950 through 1984. J Urol 1991 146, 1007–1009

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Division of Andrology, Santa Casa Hospital/Federal Faculty Foundation of Medical Sciences of Porto Alegre, Brazil

    EL Rhoden, C Teloken, HY Ting, ML Lucas, C Teodósio da Ros & C Ary Vargas Souto

Authors
  1. EL Rhoden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Teloken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. HY Ting
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. ML Lucas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Teodósio da Ros
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C Ary Vargas Souto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to EL Rhoden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rhoden, E., Teloken, C., Ting, H. et al. Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil. Int J Impot Res 13, 291–293 (2001). https://doi.org/10.1038/sj.ijir.3900727

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3900727

Keywords

This article is cited by

Search

Advanced search

Quick links